Condensed Statements of Operations (Unaudited) (Parenthetical) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Defined Benefit Plan Disclosure [Line Items]
Cost of revenue	$ 25,373	$ 55,817	$ 52,127	$ 156,665
Research and development expense	1,978,756	1,671,187	4,063,404	3,370,070
Related Party [Member]
Defined Benefit Plan Disclosure [Line Items]
Cost of revenue				46,635
Research and development expense	$ 386,507	$ 74,733	$ 761,700	$ 152,196